The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

The world’s most advanced early detection test for testicular cancer – now the most common form of cancer among young men – ...

EDX Medical has developed a new non-invasive prostate cancer test it hopes will transform diagnosis and detection of the disease. The purpose of the Cambridge, UK-based company’s test is to ...

The test was developed by EDX Medical Group, based at Cambridge Science Park, and is hoped to be launched, with regulatory approval, later this year or in early 2026. Professor Sir Chris Evans ...

EdX offers some of our favorite online learning ... We may receive products free of charge from manufacturers to test. This does not drive our decision as to whether or not a product is featured ...

The test is being launched in the UK by EDX Medical, a Cambridge-based company which specialises in developing and supplying digitally enhanced diagnostic tools for cancer, cardiovascular and ...

The world’s most advanced early detection test for testicular cancer – now the most common form of cancer among young men – is being launched in the UK. The non-invasive test has 97% sensitivity in a ...

The world's most advanced early detection test for testicular cancer now the most common form of cancer among young men is being launched in the UK. The non-invasive test has exceptional sensitivity ...